Barclays Adjusts Price Target on CME to $208 From $228
CME (CME) has an average outperform rating and price target range of $187 to $250, according to analysts polled by Capital IQ.Price: 194.50, Change: -0.12, Percent Change: -0.06
Jefferies Maintains CME Group(CME.US) With Buy Rating, Cuts Target Price to $223
Jefferies analyst Daniel Fannon maintains $CME Group(CME.US)$ with a buy rating, and adjusts the target price from $239 to $223.According to TipRanks data, the analyst has a success rate of 65.7%
Jefferies Sticks to Its Buy Rating for CME Group (CME)
Piper Sandler lowered the target price of CME Group to $235.
On July 10, Guilonghui reported that Piper Sandler has lowered its target price for CME Group from $250 to $235, while maintaining a "shareholding" rating.
Barclays Maintains CME Group(CME.US) With Hold Rating, Cuts Target Price to $208
Barclays analyst Benjamin Budish maintains $CME Group(CME.US)$ with a hold rating, and adjusts the target price from $228 to $208.According to TipRanks data, the analyst has a success rate of 65.8%
Express News | CME Group Inc : Jefferies Cuts Target Price to $223 From $239
Deep Dive Into CME Gr Stock: Analyst Perspectives (8 Ratings)
8 analysts have expressed a variety of opinions on CME Gr (NASDAQ:CME) over the past quarter, offering a diverse set of opinions from bullish to bearish.The table below provides a concise overview
CME Group Price Target Cut to $235.00/Share From $250.00 by Piper Sandler
CME Group Price Target Cut to $235.00/Share From $250.00 by Piper
CME Group Is Maintained at Overweight by Piper Sandler
CME Group Is Maintained at Overweight by Piper
Piper Sandler Maintains Overweight on CME Gr, Lowers Price Target to $235
Piper Sandler analyst Richard Repetto maintains CME Gr with a Overweight and lowers the price target from $250 to $235.
Piper Sandler Maintains CME Group(CME.US) With Buy Rating, Cuts Target Price to $235
Piper Sandler analyst Patrick Moley maintains $CME Group(CME.US)$ with a buy rating, and adjusts the target price from $250 to $235.According to TipRanks data, the analyst has a success rate of 76.1%
CME Group (CME) Receives a Buy From Piper Sandler
Goldman Sachs Adjusts Price Target on CME Group to $191 From $192, Maintains Sell Rating
CME Group (CME) has an average rating of outperform and price targets ranging from $187 to $250, according to analysts by Capital IQ.
Express News | CME Group Inc : Piper Sandler Cuts Target Price to $235 From $250
CME Group (NASDAQ:CME): The Next Great Dividend Stock
Betting on Unknown Future Events May Be the Next Big Thing in Hedging Your Investments
By Gordon Gottsegen New exchanges allow people to trade event contracts, adding credibility to a relatively new - and risky - financial instrument There's no denying that the latest reading of the con
CME Group Announces Executive Shift and Board Vacancy
Express News | Market news: CME Group has appointed Mike Dennis as its global head of fixed income.
Express News | CME Group Appoints Mike Dennis as Global Head of Fixed Income
Income Investing: 7 Safe Nonbank Financial Stocks With Attractive Payouts -- Barron's
By Lawrence C. Strauss When it comes to financial stocks, banks command a lot of the attention from income investors. But there are other options in that sector for those willing to look beyond regi